Using microarrays to predict resistance to chemotherapy in cancer patients

Pharmacogenomics
Chung-Hae Lee, Pascale F Macgregor

Abstract

Chemotherapy resistance remains a major obstacle to successful treatment and better outcome in cancer patients. The advent of whole genome experimental strategies, such as DNA microarrays, has transformed the way researchers approach cancer research. There is considerable hope that microarray technology will lead to the identification of new targets for therapeutic intervention, a better understanding of the disease process, and, ultimately, to higher survival rates and more personalized medicine. The question at hand is what is the best approach to apply these new technologies to the study of anticancer drug resistance, and how can the results obtained in the laboratory be quickly moved to a clinical setting? This review offers an overview of the microarray technology, including its recently associated strategies, such as array comparative genomic hybridization and promoter arrays. It also highlights some recent examples of microarray studies, which represent a first step toward a better understanding of drug resistance in cancer and, ultimately, personalized medicine.

References

Oct 3, 1996·The New England Journal of Medicine·R GorlickJ R Bertino
Dec 31, 1997·Genes, Chromosomes & Cancer·S Solinas-ToldoP Lichter
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M B EisenD Botstein
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G DamiaM D'Incalci
Dec 3, 1999·Biochimica Et Biophysica Acta·D R HipfnerS P Cole
Mar 4, 2000·Nature Genetics·U ScherfJ N Weinstein
Apr 5, 2000·Nature Biotechnology·E WangF M Marincola
Aug 30, 2000·Nature·C M PerouD Botstein
Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L LeeJ Sklar
Nov 9, 2000·The New England Journal of Medicine·M EstellerJ G Herman
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·S SperandioD E Bredesen
Feb 24, 2001·Annals of the New York Academy of Sciences·L F LiuS P Sim
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·V G TusherG Chu
Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Yves PommierGary S. Laco
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·J E StauntonT R Golub
Jan 31, 2002·Annual Review of Medicine·Michael M Gottesman
Feb 2, 2002·Nature·Laura J van 't VeerStephen H Friend
Feb 8, 2002·Cell·Ricky W JohnstoneScott W Lowe
Apr 6, 2002·Bioinformatics·Winston Patrick KuoIsaac S Kohane
May 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Robert TibshiraniGilbert Chu
Jul 31, 2002·The Journal of Biological Chemistry·Hisaya KawateLawrence A Loeb
Aug 7, 2002·The Journal of Nutrition·Pearlly S YanTim Hui-Ming Huang
Sep 21, 2002·Oncogene·Melanie EhrlichPeter W Laird
Sep 26, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jonathan R PollackPatrick O Brown
Nov 9, 2002·Bioinformatics·Olga G TroyanskayaRuss B Altman
Nov 28, 2002·Nature Genetics·John Quackenbush
May 2, 2003·Bioinformatics·K DobbinR Simon
Jul 2, 2003·Nature Reviews. Cancer·Roshan Agarwal, Stan B Kaye
Sep 3, 2003·European Journal of Haematology·Jeong N LeeMaher Albitar
Sep 18, 2003·Journal of the National Cancer Institute·Kevin DobbinRichard Simon
Oct 31, 2003·Trends in Genetics : TIG·Yuk Fai Leung, Duccio Cavalieri
Nov 19, 2003·PLoS Biology·David WangJoseph L DeRisi

❮ Previous
Next ❯

Citations

Nov 20, 2012·European Journal of Drug Metabolism and Pharmacokinetics·Yasmine M ElmorsiMokhtar M Mabrouk
Feb 28, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Steven G GrayKenneth J O'Byrne
Apr 19, 2006·International Journal of Radiation Oncology, Biology, Physics·Ken-ichi IshikawaTakashi Imai
Oct 27, 2005·Ageing Research Reviews·James E Galvin, Stephen D Ginsberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.